Disease Info Card

Waardenburg Syndrome Type 2

Information about Waardenburg Syndrome Type 2: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.

Overview of Waardenburg Syndrome Type 2

Most recent studies have shown that Waardenburg Syndrome Type 2 shares some biological mechanisms with albers-schonberg-disease, albinism, albinism-and-complete-nerve-deafness, albinism-ocular, albinism-oculocutaneous, catatrichy, complete-hearing-loss, crest-syndrome, haploinsufficiency, hirschsprung-disease, hypopigmentation-disorder, iris-diseases, malignant-neoplasms, malignant-paraganglionic-neoplasm, microphthalmos, pigmentation-disorders, sensorineural-hearing-loss-(disorder), waardenburg-syndrome, waardenburg-syndrome-type-i-(disorder), white-forelock.

Among the many pathways, these few ones have gauged particular interests from scientists studying Waardenburg Syndrome Type 2, and have been seen in publications frequently: Aging, Cell Migration, Localization, Melanocyte Differentiation, Neural Crest Cell Migration, Pathogenesis, Pigment Accumulation, Pigmentation, Translation, Transport

Quite a number of genes have been found to play important roles in Waardenburg Syndrome Type 2, such as DAPK3, DCT, EDN3, EDNRB, ELN, GJB2, KIT, LEF1, MITF, PAX3, PTGDS, RPE, SNAI2, SOX10, SS18L1, TYR, TYRP1, ZGPAT. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.

In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.